ALEXANDRIA, VirginiaThe American Society of Clinical Oncology
(ASCO) has launched the first study aimed at developing a national
monitoring system for cancer care in the United States. A panel of
ASCO physicians and other health experts will oversee the study,
which will be conducted by researchers at Harvard University and the
RAND Corporation, the organization said in a news release.
The 18-month pilot study, which began last month, will assess the
feasibility of a national cancer care monitoring system and develop a
prototype for such a system by examining the quality of care received
by a sample group of adult breast and colorectal cancer patients.
This study is a constructive response to the Institute of
Medicines April 1999 report Ensuring Quality Cancer Care, which
called for improved information about the quality of cancer care
nationwide, said Joseph V. Simone, MD, co-author of the IOM
report and clinical director of the Huntsman Cancer Institute,
University of Utah. I applaud ASCOs initiative in taking
a leadership role so quickly, and at such a critical time.
ASCO is joined in this effort by the American College of Surgeons,
the Society of Surgical Oncology, the American Society for
Therapeutic Radiology and Oncology, the Society of Gynecologic
Oncologists, and the Oncology Nursing Society.
The Susan G. Komen Breast Cancer Foundation will provide $1 million
in funding toward the study. Other contributors include Bristol-Myers
Squibb, Amgen, Inc., Aventis Pharmaceuticals, Agouron
Pharmaceuticals, Inc., and Ortho Biotech.